Prenosis is a biology-based technology company redefining the standard of care for critical conditions. They believe healthcare should not follow a one-size-fits-all model. Instead, their mission is to tailor healthcare to each patient's biology through the creation and delivery of integrated diagnostics and therapeutics. Prenosis uses deep data and AI to build tools that augment clinical diagnosis of critical conditions based on each patient's unique biological profile. Unlike other AI-driven diagnostics, they go further by developing therapies that help providers deliver personalized care. Their Immunix™ platform powers the development of a variety of AI-based diagnostics, including Sepsis ImmunoScore®, the first FDA-authorized AI diagnostic tool for sepsis.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
01/29/26	$20,000,000	Series A	Carle Health Global Health Investment Corporation Illinois Department of Commerce and Economic Opportunity Labcorp Venture Fund PACE Healthcare Capital UC Investments UCI Health Ventures	undisclosed